Mayo Clinic researchers will conduct an early-stage clinical trial of the use of stem cells to stop the progression of amyotrophic lateral sclerosis. Autologous modified fat-derived mesenchymal stem cells will be infused through a spinal tap to promote nerve cell survival.
Researchers explore stem cell therapy for amyotrophic lateral sclerosis
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||